- N-[(10-Oxido-9,10-dihydro-9-oxa-10-phosphaphenanthrene)methyl]-1,3,5-triazine-2,4,6-triamine
- N10-(Trifluoroacetyl)pteroic acid
- N-[1,1'-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-2-amine
- N-[1,1'-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-3-amine
- N-[1,1'-Biphenyl]-4-yl-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine
- N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide
- N'-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N'-methyl-L-lysine
- N1,1-Diphenyl-1,2-ethanediamine
- N-(1,2-Dimethylpropyl)-2-pyridinamine
- 1-(3,4-DIMETHYL-5-ISOXAZOLYL)SULFANIL-AMIDE LITHIUM SALT ">N1-(3,4-DIMETHYL-5-ISOXAZOLYL)SULFANIL-AMIDE LITHIUM SALT
- 37734-89-71H-Imidazole,2-phenyl-1-(phenylmethyl)-
- 377-36-6Butane,1,1,2,2,3,3,4,4-octafluoro-
- 37736-82-6Cyclohexanepropanoicacid, a-[[(1,1-dimethylethoxy)carbonyl]amino]-,(aS)-
- 377-37-7Butanediamide,2,2,3,3-tetrafluoro-
- 377-38-8Butanedioic acid,2,2,3,3-tetrafluoro-
- 377-40-2Cyclobutane,1,2-dibromo-1,2,3,3,4,4-hexafluoro-
- 37742-12-44-Bromo-2,2-diphenylbutyricacid
- 37742-98-6Benzeneacetic acid, α-(2-bromoethyl)-α-phenyl-
- 37743-18-3Methanaminium,N-(dihydro-3,3-diphenyl-2(3H)-furanylidene)-N-methyl-, bromide (1:1)
- 37745-01-0Pyridinium, 1-methyl-4-[2,2,2-trifluoro-1-(hydroxyimino)ethyl]-, chloride (1:1)
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
N,N-Dimethyl-10-(3-(4-(methylsulfonyl)-1-piperazinyl)propyl)phenothiazine-2-sulfonamide |
EINECS | N/A |
| CAS No. | 3773-37-3 | Density | 1.45g/cm3 |
| PSA | 123.30000 | LogP | 4.60930 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C22H30N4O4S3 | Boiling Point | 687.3°C at 760 mmHg |
| Molecular Weight | 510.74 | Flash Point | 369.5°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. Human effects by ingestion: sleep, excitement, nausea or vomiting. When heated to decomposition it emits very toxic fumes of NOx and SOx. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
RP 9260;9260 RP; |
N,N-Dimethyl-10-(3-(4-(methylsulfonyl)-1-piperazinyl)propyl)phenothiazine-2-sulfonamide Chemical Properties
IUPAC Name: N,N-Dimethyl-10-[3-(4-methylsulfonylpiperazin-1-yl)propyl]phenothiazine-2-sulfonamide
Synonyms of N,N-Dimethyl-10-(3-(4-(methylsulfonyl)-1-piperazinyl)propyl)phenothiazine-2-sulfonamide (CAS NO.3773-37-3):10H-Phenothiazine-2-sulfonamide, N,N-dimethyl-10-(3-(4-(4-methylsulfonyl)-1-piperazinyl)propyl)-(9CI) ; Phenothiazine-2-sulfonamide, N,N-dimethyl-10-(3-(4-(methylsulfonyl)-1-piperazinyl)propyl)-
InChI: InChI=1/C21H29NO.ClH/c1-15-9-7-10-16(2)19(15)21(23-14-13-22(5)6)20-17(3)11-8-12-18(20)4;/h7-12,21H,13-14H2,1-6H3;1H
InChI: InChI=1/C22H30N4O4S3/c1-23(2)33(29,30)18-9-10-22-20(17-18)26(19-7-4-5-8-21(19)31-22)12-6-11-24-13-15-25(16-14-24)32(3,27)28/h4-5,7-10,17H,6,11-16H2,1-3H3
InChIKey: GCQSBCDRVDTMSX-UHFFFAOYAM
Std. InChI: InChI=1S/C22H30N4O4S3/c1-23(2)33(29,30)18-9-10-22-20(17-18)26(19-7-4-5-8-21(19)31-22)12-6-11-24-13-15-25(16-14-24)32(3,27)28/h4-5,7-10,17H,6,11-16H2,1-3H3
Std. InChIKey: GCQSBCDRVDTMSX-UHFFFAOYSA-N
CAS NO: 3773-37-3
Molecular Formula: C22H30N4O4S3
Molecular Weight: 510.693
Molecular Structure : .png)
H bond acceptors: 8
H bond donors: 0
Freely Rotating Bonds: 7
Polar Surface Area: 123.3 Å2
Index of Refraction: 1.692
Molar Refractivity: 134.84 cm3
Molar Volume: 351.9 cm3
Surface Tension: 73.5 dyne/cm
Density: 1.45 g/cm3
Flash Point: 369.5 °C
Enthalpy of Vaporization: 100.76 kJ/mol
Boiling Point: 687.3 °C at 760 mmHg
Vapour Pressure: 9.67E-19 mmHg at 25°C
N,N-Dimethyl-10-(3-(4-(methylsulfonyl)-1-piperazinyl)propyl)phenothiazine-2-sulfonamide Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| human | TDLo | oral | 2mg/kg (2mg/kg) | BEHAVIORAL: SLEEP BEHAVIORAL: EXCITEMENT GASTROINTESTINAL: NAUSEA OR VOMITING | Psychopharmacologia Vol. 2, Pg. 209, 1961. |
| mouse | LD50 | intraperitoneal | 480mg/kg (480mg/kg) | Psychopharmacologia Vol. 2, Pg. 209, 1961. | |
| mouse | LD50 | intravenous | 310mg/kg (310mg/kg) | Psychopharmacologia Vol. 2, Pg. 209, 1961. | |
| mouse | LD50 | oral | 1300mg/kg (1300mg/kg) | Psychopharmacologia Vol. 2, Pg. 209, 1961. | |
| mouse | LD50 | subcutaneous | > 2500mg/kg (2500mg/kg) | Psychopharmacologia Vol. 2, Pg. 209, 1961. |
N,N-Dimethyl-10-(3-(4-(methylsulfonyl)-1-piperazinyl)propyl)phenothiazine-2-sulfonamide Safety Profile
Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. Human effects by ingestion: sleep, excitement, nausea or vomiting. When N,N-Dimethyl-10-(3-(4-(methylsulfonyl)-1-piperazinyl)propyl)phenothiazine-2-sulfonamide (CAS NO.3773-37-3) is heated to decomposition, it emits very toxic fumes of NOx and SOx.
What can I do for you?
Get Best Price
